| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/28/2009 | WO2008104954A3 Personal care product comprising cyclodextrin as fragrance-complexing material |
| 05/28/2009 | WO2008098789A3 Dual acting prodrugs |
| 05/28/2009 | WO2008089248A3 Amphiphilic substances and triggered liberation from lipid vesicles |
| 05/28/2009 | US20090137688 Pharmaceutical product |
| 05/28/2009 | US20090137677 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137676 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137675 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137674 Administering L-lysine-d-amphetamine or salts |
| 05/28/2009 | US20090137673 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137672 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137663 Therapeutic micro nutrient composition for drug delivery |
| 05/28/2009 | US20090137633 Stable pharmaceutical composition of rabeprazole |
| 05/28/2009 | US20090137515 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090137494 Tumor-activated prodrug compounds and treatment |
| 05/28/2009 | US20090137491 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137490 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137489 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137488 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137487 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137486 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137483 Antagonists of the bradykinin B1 receptor |
| 05/28/2009 | US20090137461 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137452 Antagonists of the bradykinin B1 receptor |
| 05/28/2009 | US20090136980 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle |
| 05/28/2009 | US20090136928 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 05/28/2009 | US20090136585 Surface-modified nanoparticles for intracellular delivery of therapeutic agents and composition for making same |
| 05/28/2009 | US20090136573 Methods for Making and Delivering Rho-Antagonist Tissue Adhesive Formulations to the Injured Mammalian Central and Peripheral Nervous Systems and uses Thereof |
| 05/28/2009 | US20090136572 Emulsified composition for dilution and cancer vaccine composition |
| 05/28/2009 | US20090136564 Micelles |
| 05/28/2009 | US20090136542 Immunogenic composition and method of developing a vaccine based on portions of the HIV matrix protein |
| 05/28/2009 | US20090136539 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 05/28/2009 | US20090136536 Recombinant Subunit Vaccine |
| 05/28/2009 | US20090136467 Apolipoprotein analogues |
| 05/28/2009 | US20090136410 Stabilization and ionic triggering of nitric oxide release |
| 05/28/2009 | CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 05/28/2009 | CA2706472A1 Preparations, methods and kits useful for treatment of cough |
| 05/28/2009 | CA2706440A1 Preparations, methods and kits useful for treatment of cough |
| 05/28/2009 | CA2706404A1 Preparation for body surface application and preparation for body suface application-holding sheet |
| 05/28/2009 | CA2706201A1 Peptides with capacity to bind to scurfin and applications |
| 05/28/2009 | CA2705988A1 Stabilisation of oily suspensions containing hydrophobic silicic acids |
| 05/28/2009 | CA2705965A1 External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 05/28/2009 | CA2705588A1 System for delivery into a xcr1 positive cell and uses thereof |
| 05/28/2009 | CA2695605A1 Pyrazolone derivative emulsion formulations |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062599A1 Orally disintegrating tablet and process for production thereof |
| 05/27/2009 | EP2062598A1 Gel type enteric nutrient |
| 05/27/2009 | EP2062592A1 System for delivery into a XCR1 positive cell and uses thereof |
| 05/27/2009 | EP2062585A1 The antibiotics composition comprising aminoglycoside antibiotics |
| 05/27/2009 | EP2062584A1 Adhesive preparation |
| 05/27/2009 | EP2062582A1 The antibiotics composition comprising beta-lactam antibiotics and buffers |
| 05/27/2009 | EP2062581A1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents |
| 05/27/2009 | EP2062579A1 Solid pharmaceutical composition for oral administration comprising optically stable ramosetron |
| 05/27/2009 | EP2062576A1 Adhesive preparation |
| 05/27/2009 | EP2062575A1 Adhesive preparation |
| 05/27/2009 | EP2062574A1 Composition comprising reduced coenzyme q10 and lysolecithin |
| 05/27/2009 | EP2062573A1 Abuse resistant opioid containing transdermal systems |
| 05/27/2009 | EP2062571A1 Self-emulsifying pharmaceutical composition with enhanced bioavailability |
| 05/27/2009 | EP2061816A1 Hyaluronic acid derivatives obtained via "click chemistry" crosslinking |
| 05/27/2009 | EP2061814A2 Antibodies and immunoconjugates and uses therefor |
| 05/27/2009 | EP2061772A2 Multi-functional small molecules as anti-proliferative agents |
| 05/27/2009 | EP2061655A1 Appliance for delivering a composition, the appliance having an elastic layer and a shielding layer |
| 05/27/2009 | EP2061654A1 Appliance for delivering a composition, the appliance having an outer fibrous layer and inner liquid-impermeable layer |
| 05/27/2009 | EP2061512A1 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 05/27/2009 | EP2061505A2 Composition for eliciting a specific ctl response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cells |
| 05/27/2009 | EP2061481A2 Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 05/27/2009 | EP2061454A1 Compositions comprising a c2-c14 carboxylic acid and a surfactant for treating hoof diseases |
| 05/27/2009 | EP2061443A2 Polyconjugates for in vivo delivery of polynucleotides |
| 05/27/2009 | EP2061433A2 Compositions and methods for enhancing transport through mucus |
| 05/27/2009 | EP2061432A1 Nano-vehicle for the transcutaneous transport, preparation containing the same and its use |
| 05/27/2009 | EP2061428A1 Improvements in pharmaceutical compositions |
| 05/27/2009 | EP1877095B1 The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 05/27/2009 | EP1635770B1 Antifungal nail coat and method of use |
| 05/27/2009 | EP1617277B1 Ophthalmic lenses capable of sustained drug release and preservative solutions therefor |
| 05/27/2009 | EP1606381B1 Coated enzyme granules |
| 05/27/2009 | EP1509246B1 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 05/27/2009 | EP1485080B1 Use of adapalene for the treatment of dermatological disorders |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP1299086A4 Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives |
| 05/27/2009 | EP1130966B2 Antiparasitic formulations |
| 05/27/2009 | CN101443045A Agent-enriched nanoparticles based on hydrophilic proteins |
| 05/27/2009 | CN101443044A Dextran and arabinogalactan conjugates of therapeutically active compounds |
| 05/27/2009 | CN101443043A Antibody compositions and methods |
| 05/27/2009 | CN101443038A Nicotine-carrier vaccine formulation |
| 05/27/2009 | CN101443018A Sterilized nanoparticulate glucocorticosteroid formulations |
| 05/27/2009 | CN101442993A Adhesive preparation |
| 05/27/2009 | CN101442982A Stomach floater composition containing optimization treated starch for inducing satiation sense |
| 05/27/2009 | CN101441161A Particle-stabilised emulsions |
| 05/27/2009 | CN101440379A Obtaining method and use of novel oncolytic adenovirus construct with selective tumor blockage STAT3 |
| 05/27/2009 | CN101440378A Construction scheme and use of recombinant adeno related virus containing 16 type HPV antisense E7 gene |
| 05/27/2009 | CN101440136A Preparation of amine saccharification chitosan complex |
| 05/27/2009 | CN101440113A Colchicine derivative-bile acid coupling compounds and medical use thereof |
| 05/27/2009 | CN101439206A Preparation of enzyme-catalyzed rapid-solidified hydrogel and use thereof |
| 05/27/2009 | CN101439188A Polymer lyophilized preparation of insoluble anti-tumor medicament |
| 05/27/2009 | CN101439187A Novel coupling compound of bile acid and anti-hepatitis virus medicament and medical use thereof |
| 05/27/2009 | CN101439186A Oral cavity rapid release western medicine preparation and preparation thereof |